Clinical trial · Observational
Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome Health-related Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| mPCOSQ-F and SF-36 | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Polycystic ovary syndrome
- description
- patients with Polycystic ovary syndrome
- interventionNames
- Other: mPCOSQ-F and SF-36
Primary outcomes (11)
- measure
- Content validity of mPCOSQ as determined by the experts group
- timeFrame
- At 2 years
- measure
- Feasibility of mPCOSQ
- timeFrame
- At 2 years
- measure
- Acceptability of mPCOSQ
- timeFrame
- At 2 years
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion criteria: * Women aged 18 to 45 * Fluent in french * Having a diagnosis of PCOS according to the international recommendations published in 2023 * Willing to participate in the study * Affiliated to the french social security system Exclusion criteria: * Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder * Pregnancy or breast-feeding * Under legal protection
References
Publications (0)
Data not yet available